Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01425151
Other study ID # Schulthess_Anä_2
Secondary ID
Status Completed
Phase N/A
First received August 26, 2011
Last updated September 20, 2011
Start date January 2010
Est. completion date September 2011

Study information

Verified date September 2011
Source Schulthess Klinik
Contact n/a
Is FDA regulated No
Health authority Austria : Federal Ministry for Labour, Health, and Social Affairs
Study type Interventional

Clinical Trial Summary

In the following randomized, crossover study, the investigators test the hypothesis that ease of insertion and oropharyngeal leak pressure differ between the LMA ProSealTM and the i-GelTM in anesthetized pediatric patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 2011
Est. primary completion date September 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Months to 6 Years
Eligibility Inclusion Criteria:

- ASA I and II

- Age 1.5-6 years

Exclusion Criteria:

- known or predicted difficult airway

- body mass index > 35 kg m-2

- risk of aspiration

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Device:
i-Gel
Oropharyngeal leak pressure Insertion success
ProSeal
Oropharyngeal leak pressure Insertion success

Locations

Country Name City State
Austria Klinik für Anästhesie und Allgemeine Intensivmedizin Innsbruck
Switzerland Christian Keller Zürich

Sponsors (1)

Lead Sponsor Collaborator
Schulthess Klinik

Countries where clinical trial is conducted

Austria,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Oropharyngeal leak pressure 10 Minutes Yes
Secondary Insertion success rate 1 Minute Yes